from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2188c/pimB

LFCtreatmentdescriptionclass of inhibitor

0.674

Amikacinug/mL Amikacintranslation

0.881

Cap5-10ug/mL Capreomycintranslation

1.810

Rox10-50 ug/mL Roxithromycintranslation

-0.425

SM2-5 ug/mL Streptomycintranslation

2.341

Tet5-10 ug/mL Tetracyclinetranslation

-0.083

Rif0.2-5ug/mL Rifampicintranscription

-0.263

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.902

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.336

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.460

CPZ10-50 ug/mL Chlorpromazinerespiration

0.056

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.098

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.891

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.120

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.004

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.223

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.684

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.882

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.982

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.602

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.047

KCN5-20 ug/mL Potassium cyaniderespiration

0.272

NaN30.2-2 mM Sodium aziderespiration

-0.913

Nigericin50 uM Nigericinrespiration

0.382

TRC10-150 ug/mL Triclosanrespiration

-0.131

TRZ10-25 ug/mL Thioridazinerespiration

1.314

Valinomycin0.5-10 uM Valinomycinrespiration

-0.299

ZnSO42 mM ZnSO4respiration

-1.066

menadione6-10 ug/mL Menadionerespiration

-0.634

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.802

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.401

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.482

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.419

NRP_1Non-replicating persistence stage 1dosRassociated

-0.205

Amp0.2mg/mL AmpicillincellWall

-0.227

Cephalexin20-100 ug/mL CephalexincellWall

-0.416

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.531

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.307

EMB10-20 ug/mL EthambutolcellWall

0.104

Eta12-40 ug/mL EthionamidecellWall

0.647

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.249

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.336

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.083

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.006

BZA0.12 mg/mL BenzamidearomaticAmides

0.824

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.677

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.273

H2O24 mM hydrogen peroxideDNAdamaging

-0.388

Levo10 ug/mL LevofloxacinDNAdamaging

-0.054

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.803

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.260

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.008

UVUV-irradiationDNAdamaging

-0.179

ARP41-4 ug/mL Antitubercular compound ARP4?

0.279

Antimycin12.5-50 ug/mL Antimycin A?

-0.884

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.513

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.122

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.171

PA8240.2-2 ug/mL PA-824?

0.507

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.075

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.225

Verapamil50 uM Verapamil?

-1.329

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.352

methoxatin10-20 ug/mL Methoxatin?